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Endogenous retinoids are important for patterning many aspects of the embryo including the branchial arches and frontonasal region of
the embryonic face. The nasal placodes express retinaldehyde dehydrogenase-3 (RALDH3) and thus retinoids from the placode are a
potential patterning influence on the developing face. We have carried out experiments that have used Citral, a RALDH antagonist, to address
the function of retinoid signaling from the nasal pit in a whole embryo model. When Citral-soaked beads were implanted into the nasal pit of
stage 20 chicken embryos, the result was a specific loss of derivatives from the lateral nasal prominences. Providing exogenous retinoic acid
residue development of the beak demonstrating that most Citral-induced defects were produced by the specific blocking of RA synthesis. The
mechanism of Citral effects was a specific increase in programmed cell death on the lateral (lateral nasal prominence) but not the medial side
(frontonasal mass) of the nasal pit. Gene expression studies were focused on the Bone Morphogenetic Protein (BMP) pathway, which has a
well-established role in programmed cell death. Unexpectedly, blocking RA synthesis decreased rather than increased Msx1, Msx2, and
Bmp4 expression. We also examined cell survival genes, the most relevant of which was Fgf8, which is expressed around the nasal pit and in
the frontonasal mass. We found that Fgf8 was not initially expressed along the lateral side of the nasal pit at the start of our experiments,
whereas it was expressed on the medial side. Citral prevented upregulation of Fgf8 along the lateral edge and this may have contributed to the
specific increase in programmed cell death in the lateral nasal prominence. Consistent with this idea, exogenous FGF8 was able to prevent
cell death, rescue most of the morphological defects and was able to prevent a decrease in retinoic acid receptorh (Rarh) expression caused
by Citral. Together, our results demonstrate that endogenous retinoids act upstream of FGF8 and the balance of these two factors is critical for
regulating programmed cell death and morphogenesis in the face. In addition, our data suggest a novel role for endogenous retinoids from the
nasal pit in controlling the precise downregulation of FGF in the center of the frontonasal mass observed during normal vertebrate
development.
D 2004 Elsevier Inc. All rights reserved.
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Vitamin A derivatives or retinoids are critical for many
aspects of embryo development as amply demonstrated in
the offspring of vitamin A-deficient animals (Clagett-Dame
and DeLuca, 2002; Ross et al., 2000; Zile, 2001). Vitamin A
is taken in through the maternal diet and locally metabolized0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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enzymes required for conversion of retinol to retinoic acid
include 4 members of the retinaldehyde dehydrogenase
enzyme family, RALDH1-4 (ALDH1a1-4) (Duester et al.,
2003; Lin et al., 2003). Once metabolized in the cytosol,
retinoic acid binds to three types of nuclear retinoic acid
receptors (RARa, h, g). The RARs may dimerize with RXR
receptors leading to activation of downstream genes,
however, unliganded retinoic acid receptors can repress
transcription by recruitment of other cofactors (Weston et
al., 2003). Targeted deletion of RALDH2 (Niederreither et
al., 1999) followed by partial rescue through administration276 (2004) 313–329
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revealing a requirement for patterning the heart (Nieder-
reither et al., 2001), posterior branchial arches (Nieder-
reither et al., 2003), limbs (Niederreither et al., 2002), and
brain (Niederreither et al., 2002), however, no effects on
craniofacial development were described. This may be
because several RALDH genes are expressed in the embryo
and there may be some compensation by other family
members. Blocking slightly higher up the pathway, recent
studies have shown that retinal conversion from retinol has
specific effects on the craniofacial skeleton (Lampert et al.,
2003). Blocking the pathway at the lowest point by deleting
nuclear retinoic acid receptors leads to defects in fusion of
the primary palate (Lohnes et al., 1994). Thus, it is likely
that retinoid signaling is required for some aspects of
craniofacial morphogenesis; however, global knockout
models are not precise enough to tell us where critical
levels of retinoids are required.
Our previous work has shown that levels of retinoids are
one signal required for establishing frontonasal mass
identity (Lee et al., 2001). Increased retinoid acid levels in
combination with blocking of BMP signaling lead to
transformation of the side of the beak (derived from the
maxillary prominence) into a second set of midline
structures (derived from the frontonasal mass). These
experiments suggested it is necessary to have a source of
endogenous retinoids to pattern the frontonasal mass and its
derivatives, the prenasal and premaxillary skeletal elements.
Two of the retinoic acid synthesis enzymes are expressed at
high levels in the nasal placodes, RALDH2 which is
expressed in the mesenchyme under the placode (Berggren
et al., 1999; Bhasin et al., 2003) and RALDH3 which is
expressed in the epithelium (Blentic et al., 2003; Mic et al.,
2000). Furthermore, expression of a reporter gene under the
control of a retinoic acid response element (RARE) is very
strong in the nasal placodes of transgenic mice (Nieder-
reither et al., 2002). We hypothesized that RA synthesized in
the placode and nasal pit could be used in patterning both
the lateral nasal prominence and frontonasal mass.
The blocking of retinoid synthesis or signaling in chicken
embryos during neural crest cell migration stages has shown
that retinoids are required for forebrain development and the
lack of brain growth secondarily affects upper beak
formation (Schneider et al., 2001). In the present study,
we work at later stages and specifically target the nasal pit
with the chemical Citral, an inhibitor of retinaldehyde
dehydrogenases (Gagnon et al., 2002; Kikonyogo et al.,
1999). We examined the effects of blocking retinoid
synthesis on craniofacial development and conducted rescue
experiments with RA to test the specificity of Citral on
retinaldehyde dehydrogenase. We then looked at gene
expression changes between stages 20 and 24 for several
genes that are in the retinoid pathway and could provide a
mechanism for the development of the skeletal phenotype.
Finally, we tested whether one of the proteins downstream
of endogenous retinoids-FGF8-could rescue development.Our results support the idea that endogenous retinoids from
the nasal pit play dynamic and important roles in regulating
Fgf8 expression and subsequent morphogenesis in the
embryo.Methods
Bead implants
SM2 beads (200 Am diameter, BioRad) were soaked in
several concentrations of Citral (Fluka, stock concentra-
tion = 0.888 g/ml) for 10 min as described in Schneider
et al. (2001). AG1X-2 beads (BioRad, format form, 200 Am
diameter) were soaked in various concentrations of RA
dissolved in DMSO. Both types of control beads were
soaked in DMSO. Heparin Acrylic beads (Sigma) were
soaked in 1 mg/ml FGF8b (human, Peprotech) for a
minimum of 1 h at room temperature. White leghorn eggs
were incubated at 388C until stage 20. For Citral bead
implantation, a small incision was made in the ectoderm of
the right nasal pit or center of frontonasal mass, through
which beads were pushed into the mesenchyme. FGF8b
beads were also implanted in the mesenchyme. RA beads
were placed in contact with the ectodermal lining of the
right nasal pit. The day following implantation, the treated
embryos were observed to confirm the presence of beads in
the face.
Skeletal staining and analysis
Chicken embryos were fixed at stage 38 (after 12 days of
incubation) and kept in 100% ethanol for 4 days. Next,
embryos were immersed in 100% acetone for 4 days, rinsed
in water and then stained for up to 10 days in alizarin red/
alcian blue solution (Plant et al., 2000). Specimens were
cleared in 20% glycerol/2% KOH solution followed by a
series of glycerol/H2O solutions with increasing amount of
glycerol (50%, 100%).
Morphology of each skeletal element was assessed and
described as normal, absent, or defective. The category
defective includes all morphology changes such as overall
reduction in size and loss of processes.
Whole-mount in situ hybridization and analysis of gene
expression patterns
Whole-mount in situ was performed as described in Shen
et al. (1997). Due to the dynamic expression patterns of
many of the genes, we compared expression of 3 h, 6, 16,
and 24 h embryos to non-treated embryos of a similar stage.
In this way, we could determine whether there were
possibly bilateral effects of the Citral. Hybridizations and
washes were carried out in an Intavis In situ Hybridization
Robot (InTavis, CA). Individuals who generously provided
cDNAs for this work include: Bmp4 (P. Francis-West), Fgf8
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Rarh (P. Brickell).
Whole-mount Nile Blue Sulfate and TUNEL staining for
programmed cell death
Embryos were treated with Citral for defined time
periods of 1, 3, 6, 16, and 24 h and removed from the
egg. Embryos were transferred to a plastic tube containing
10 ml PBS with 30 Al of Nile Blue Sulphate (1 mg/ml
filtered Nile Blue Sulphate in ddH2O (Jeffs et al., 1992).
Embryos were rocked gently for 30–40 min at room
temperature, washed in PBS for 30–60 min, and then
photographed immediately.
Terminal uridine nick-end labeling (TUNEL) technique
was used to detect cell death in tissue sections as described
(Shen et al., 1997). Embryos were fixed at 3, 6, and 16 h
post-treatment with beads soaked in 0.01 or 0.1 g/ml Citral.
Control embryos were fixed at the same time points. Two
sections from each treated and control embryo were placed
on the same slide and 4–5 slides were examined. Controls
for the TUNEL reaction consisted of sections treated with
DNAse I before TUNEL detection and sections in which no
enzyme was added. Sections were photographed under
bright field. Approximate numbers of dead cells were
recorded for different regions of the embryonic face on
treated and untreated sides. Each area was scored as having
0, 1–5, 5–10, 10–25, 25–50 apoptotic cells. At least four
different embryos were scored for each time point.Results
Dose–response data
Early effects on nasal pit morphogenesis
The nasal placode is first observed as a thickening of the
ectoderm at either side of the telencephalon at stage 15.
Invagination of the placode occurs to form a shallow pit at
stage 20, a nasal slit by stage 24, and finally the nasal orifice
at the sides of the beak by stage 32. The nasal pit lies in
between the lateral nasal prominence and frontonasal mass
and could potentially provide signals to both parts of the
face. The frontonasal mass makes the prenasal cartilage,
premaxilla, and nasal septum (Lee et al., 2001; Richman and
Tickle, 1989, 1992; Wedden, 1987); the lateral nasal
prominences give rise to the nasal conchae (MacDonald et
al., 2004) and nasal bone. To test the role of retinoids as
possible patterning signals, we applied beads soaked in
Citral to the nasal pit of stage 20 chicken embryos, a time
when there is very strong expression of Raldh3 in the nasal
pit (Blentic et al., 2003). Different soaking concentrations
were tested, ranging from 0.001 to 0.888 g/ml (stock
concentration) since these were expected to release different
amounts of the compound. Embryos treated with beads
soaked in 0.01 g/ml had normal invagination of the nasal pitand normal lateral nasal prominence morphology at all time
points examined (n = 20 for 1, 6, 16, and 24 h). Embryos
treated with 0.1 g/ml of Citral showed loss of nasal pit
morphology visible shortly after beads were implanted (n =
9, 1 h); however, the lateral nasal prominence was normal in
shape until 16 h (n = 5/5, Figs. 3I, J). Undiluted Citral or 0.5
g/ml led to complete loss of the lateral nasal prominence and
nasal pit on the treated side almost immediately after placing
the bead (n = 9, 1 h). The main effects appeared to be on the
lateral nasal prominence rather than the adjacent frontonasal
mass and maxillary prominences.
Effects on skeletal development
The effects of Citral beads on skeletal morphogenesis
were consistent with the early changes in morphology of the
nasal pit. Beads soaked in undiluted Citral or a concen-
tration of 0.5 g/ml ablated the entire right side of the upper
beak including all lateral nasal prominence derivatives and
most maxillary prominence derivatives (n = 13, data not
shown). As the concentration was decreased the effects
became more localized. Consistent morphological defects
were observed with 0.1 g/ml of Citral (Table 1A, Figs. 1C,
D). The major defects were seen in the derivatives of the
lateral nasal prominence, consistent with the early pheno-
type. The nasal bone and nasal conchae were absent in the
majority of specimens (Table 1A). There were also
significant abnormalities in the maxillary prominence
derivatives including the maxillary, palatine, and jugal
bones (Table 1A, Figs. 1C, D). The only frontonasal mass
derivative affected was the maxillary process of the
premaxillary bone and frequently this process was truncated
on both sides of the beak (Fig. 1D). At concentrations of
0.01 g/ml, a proportion of embryos developed normally (n =
11/28) and others had similar defects to those treated with
0.1 g/ml. Therefore, with this soaking concentration, it was
not possible to predict which embryos would recover from
the Citral and go on to develop normally. Embryos treated
with 0.001 g/ml of Citral showed normal morphology of the
skull at stage 38 (n = 7/7). DMSO-treated embryos always
developed normally and therefore cutting into the nasal
placode had no effect on development (Figs. 1A, B). We
also treated a subset of embryos with Citral-soaked beads
resting on the epithelium of the nasal placode and these had
identical effects on the skeleton (n = 13/13). Therefore,
Citral was capable of passing freely through the epithelium.
Position-specific effects
We hypothesized that the nasal placode is the main source
of retinoids in the frontonasal region and that if we placed
beads further from this source, the effects on morphogenesis
would be different. A Citral-soaked bead in the center of the
frontonasal mass led to decreased upper beak length and
deviations to the treated side, however, the morphology of
skeletal structures was mainly normal (n = 12/12, Figs. 1E,
F). Since the effects of blocking retinoid synthesis were less
pronounced than when the nasal placode was targeted, it
Table 1
Induction of skeletal and soft tissue defects in stage 38 embryos
Phenotype Prenasal cartilage Premaxillary bone Nasal conchae Nasal bone Maxillary bone Palatine bone Jugal bone
Tx UnTx Tx UnTx Tx UnTx Tx UnTx Tx UnTx Tx UnTx
(A) Effects of 0.1 g/ml of Citral on skeletal development
Absent 7 (47%) 12 (80%) 13 (87%) 3 (20%)
Defective 3 (20%) 11 (73%) 1 (7%) 8 (53%) 11 (73%) 11 (73%) 3 (20%) 10 (67%)
Normal
total
N = 15
15 (100%) 5 (33%) 4 (27%) 2 (2%) 15 (100%) 2 (13%) 15 (100%) 4 (27%) 4 (27%) 4 (27%) 12 (80%) 5 (33%) 15 (100%)
(B) Rescue of Citral induced skeletal defects by 0.75 mg/ml RA (0.1 g/ml Citral)
Absent 1 (5%) 1 (5%) 1 (5%) 3 (16%)
Defective 7 (37%) 4 (21%) 12 (63%) 3 (16%) 4 (21%) 4 (21%)
Normal
total
N = 19
11 (58%) 14 (74%) 18 (95%) 7 (37%) 19 (100%) 13 (68%) 19 (100%) 15 (79%) 19 (100%) 15 (79%) 19 (100%) 19 (100%) 19 (100%)
(C) Rescue of skeletal development by 1 mg/ml FGF8b (0.1 g/ml Citral)
Absent 2 (14%) 5 (36%) 9 (64%)
Defective 5 (36%) 5 (36%) 7 (50%) 2 (14%) 2 (14%) 5 (36%) 4 (29%) 5 (36%)
Normal
total
N = 14
14 (100%) 7 (50%) 9 (64%) 2 (14%) 12 (86%) 3 (21%) 14 (100%) 9 (64%) 14 (100%) 10 (71%) 9 (64%) 14 (100%) 14 (100%)
(D) Cleft phenotype
Phenotype Citral Citral + RA Citral + FGF8b
Non-cleft 5 (33%) 19 (100%) 10 (72%)
Unilateral 2 (13%) 2 (13%)
Bilateral 8 (53%) 2 (13%)
Total number 15 19 14
Key: RA—retinoic acid, Tx—treated, UnTx—untreated.
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Fig. 1. Skeletal morphology of embryos treated with beads soaked Citral placed in nasal pit or frontonasal mass of stage 20 embryos. Left column is the lateral
view; right column is the palatal view. Mandible has been removed before photography. (A, B) Upper beak of DMSO-treated embryos with normal skeletal
structure. (C, D) Implantation of 0.1 g/ml Citral beads into the right nasal pit of chicken embryos results in the loss of nasal conchae, nasal bone (asterisk in D).
Bilateral effects include a reduction in the maxillary bones however the palatine processes are preserved. The palatine and jugal bones are also reduced in size
on both sides. (E, F) Implantation of a bead soaked in 0.888 g/ml into the center of FNM of embryos shows normal patterning although the entire upper beak is
slightly shorter and deviated toward treated side. Key: j—jugal, l—lacrimal bone, (L)—left side, mxb—maxillary bone, mpp—maxillary process of the
premaxillary bone, n—nasal bone, nc—nasal conchae, p—palatine, pmx—premaxillary bone, pnc—prenasal cartilage, pp—palatine process of the maxilla,
qj—quadratojugal. Scale bar = 2 mm.
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synthesis at stage 20. Similar normal morphology was
obtained by blocking RA signaling at the receptor level in
stage 18 embryos (Schneider et al., 2001).
Rescue of the Citral phenotype with RA
Citral may affect other aldehyde dehydrogenases besides
those involved in RA synthesis. To determine how much of
the phenotype was due to inhibition of retinoid synthesis, we
applied exogenous RA sequentially after Citral beads were
implanted. While we and others had published the effects of
RA on outgrowth of the upper beak (Richman and Delgado,
1995; Tamarin et al., 1984; Wedden and Tickle, 1986), the
effects on the skeleton had not previously been analyzed.
Treatment with 0.75 mg/ml exogenous all trans-RA at a
similar time point (stage 20 plus 1–2 h) always resulted in the
loss of the prenasal cartilage and premaxillary bones (15/15;
Figs. 2A, B). The nasal conchae were always present in
embryos treated with only RA, though reduced in size and
abnormal in shape (15/15, Figs. 2A, B). We found that the
majority of dual-treated embryos (Citral 0.1 g/ml + RA 0.75
mg/ml) were almost normal (Figs. 2C, D) when compared to
DMSO-treated controls (Figs. 1A, B). The skeletal elements
rescued most frequently were the nasal conchae (100%) and
nasal bone (84%; Table 1B; Figs. 2C, D). Chi2 analysis
showed that there was a highly significant increase in the
presence of the nasal conchae and bones as compared to
Citral-treated embryos (P b 0.0001; Table 1A; Figs. 1C, D).
In addition, fewer maxillary derivatives (palatine, jugal and
maxillary bone) were defective in retinoic acid rescued-
embryos as compared to Citral-treated control embryos
(Table 1B, Figs. 2C, D). There was only one embryo out of
19 that had the typical RA phenotype even though Citral was
also present (Table 1B). Thus, we did not see the effects of
exogenous RA overwhelm the effects of Citral. Rather, the
RA rescued all aspects of the Citral phenotype, suggesting
that it is mainly through inhibition of RA synthesis that the
defects arise.
Temporal effects of Citral on upper beak morphogenesis
To see whether effects of Citral were reversible, we first
treated embryos with Citral for a defined period and then
removed the beads. Even beads removed after only 3 h lead to
defects in the upper beak similar to those produced by the
beads being left in place. All embryos were missing the right
nasal conchae (n = 8/8) and most had abnormally shaped
maxillary and palatine bone (n = 7/8). These results suggest
that most of the effects of Citral occur very rapidly or that
sufficient amounts of Citral remain in the tissue to sustain the
inhibition of RA synthesis. We therefore did a time course of
rescue experiments with RA to determine whether there was a
point at which RA could no longer reverse the effects of
Citral. RA Beads implanted after an initial Citral exposure of
6 h rescued the nasal conchae and nasal bone (n = 9/9). Astime between the Citral and RA implants increased, the
rescue was not as effective. A 16-h treatment with Citral
could not be rescued by RA (10/11 missing right nasal
conchae and nasal bone). This suggests that irreversible
patterning changes have already taken place by this time
(Figs. 2E, F). A similar time frame has been reported for
irreversible changes to be induced by exogenous RA (Tickle
et al., 1985; Wedden and Tickle, 1986).
Inhibition of RA synthesis leads to increased programmed
cell death
We suspected that the early changes in nasal pit
morphology and the loss of lateral nasal prominence
derivatives may be linked to a specific induction of cell
death in these regions. Two possibilities needed to be
investigated, one was that Citral-induced necrosis or that
loss of RA lead to an increase in programmed cell death.
If necrosis was the mechanism, then dead or dying cells
would be equally distributed around the bead and these
changes would be clearly visible very soon after bead
placement. However, if apoptosis was occurring then
there would be a delay in the response while a specific
downstream molecular cascade was induced. In addition,
there may not be equal responses of all tissues to the
Citral depending on the importance of elevated RA
levels in that area of the embryo. We determined that
embryos treated with 0.1 g/ml Citral-treated embryos
showed no detectable increase in programmed cell death
at 3 h either with Nile Blue Sulfate staining (n = 10/10,
Fig. 3B) or in TUNEL-stained sections (n = 4/6, Figs.
3C, D) in the lateral nasal prominence, frontonasal mass
or maxillary prominence. By 6 h, there was detectable
cell death in the lateral nasal prominence visible in
whole embryos (n = 2/7, Fig. 3F) and mesenchymal
apoptosis was obvious in tissue sections, primarily
restricted to the lateral nasal prominence (10–25 cells
per section, n = 6/6 Figs. 3G, H) and anterior maxillary
prominence (5–10 cells per section, n = 4/6). At 16 h,
there were similar numbers of TUNEL positive cells in the
lateral nasal prominence mesenchyme (10–25 cells per
section, n = 5/5, Figs. 3K, L). It was also clear that
apoptosis was not induced in the adjacent frontonasal mass
tissue, even though the bead was also contacting this tissue
(n = 11/11 of TUNEL-stained specimens; Figs. 3G, K). In
addition to induced cell death in the lateral nasal
prominence, we observed normal patterns of apoptosis
in the trigeminal ganglion, in the nasolacrimal groove,
the midline of the mandibular prominence and second
branchial arch (Figs. 3A, B, E, F, I, J). Thus, there is a
specific response in the lateral nasal prominence mesen-
chyme that sets it apart from other facial mesenchyme
and suggests that the effects of Citral are not merely
induction of cellular necrosis. In addition, apoptosis was
induced in tissue that will give rise to the frontonasal
mass by interfering with retinoic acid receptor signaling
at stage 10 (Schneider et al., 2001). Thus, RA ligand or
Fig. 2. Effective rescue with RA of the Citral phenotype. Whole-mount skeletal preparations of the skull, left column is lateral view of treated side, right
column is palatal view so treated side is uppermost. Mandible has been removed before photography. All embryos were treated at stage 20. (A, B) Implantation
of 0.75 mg/ml RA ablated prenasal cartilage and premaxilla (asterisk A, B), but maxillary bones are still present on both sides. (C, D) Implantation of 0.75 mg/
ml RA 1 h after Citral bead (0.1 g/ml) has rescued the nasal conchae, maxillary bone, and maxillary process of premaxilla but not the right nasal bone. The
palatine bones are full-length and maxillary bones are normal in size thus the quality of rescue is very good. The right nasal conchae were considered to be
defective but present. There were no external clefts in this embryo before staining. (E, F) Implantation of 0.75 mg/ml RA 16 h after Citral bead (0.1 g/ml) has
not rescued Citral phenotype. Loss of nasal bone and conchae is visible on treated side (asterisks E, F) as well as a bilateral loss of the maxillary process of
premaxilla. This embryo had a bilateral cleft. Key: j—jugal, (L) left side, mpp—maxillary process of premaxillary bone; mxb—maxillary bone, n—nasal bone,
nc—nasal conchae, p—palatine bone, qj—quadratojugal. Scale bar = 5 mm.
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and temporally restricted during development.
Endogenous RA is required to maintain expression of cell
survival gene Fgf8 and genes in the BMP pathway
The mechanism of Citral action may have been to
increase expression of genes normally associated with the
induction of the programmed cell death pathway in the face
and elsewhere in the embryo, Bmp4 (Bone morphogeneticprotein), Msx1 (Muscle segment homeobox), Msx2 (Ashi-
que et al., 2002; Barlow and Francis-West, 1997; Graham et
al., 1994). In addition, decreased RA synthesis may affect
genes in the RA pathway such as the retinoic acid receptors
and these in turn may regulate expression of genes involved
with cell survival such as Fgf8 (Abu-Issa et al., 2002;
Brondani and Hamy, 2000; Brondani et al., 2002; Trumpp et
al., 1999) and Sonic Hedgehog (Shh) (Ahlgren and
Bronner-Fraser, 1999; Sanz-Ezquerro and Tickle, 2000).
Rarh (retinoic acid receptor h) was previously shown to be
Fig. 3. Temporal sequence of cell death induction in Citral-treated embryos. (A) Normal cell death patterns visible in this stage 20.5 embryo including the
midline of the mandibular prominences (arrow). (B–D) Embryos treated with 0.1 g/ml Citral no increase in cell death in the lateral nasal prominence (box in C,
enlargement in D). Normal cell death is observed in the midline of the mandibular prominence (arrow in B). (E) Normal apoptosis at stage 21. (F) Increased cell
death in the lateral nasal prominence in an embryo treated with 0.1 g/ml soaked Citral bead (arrow). (G–H) Box in G and enlargement in H show numerous
apoptotic cells (arrows) but not in the adjacent frontonasal mass or maxillary prominences. Normal areas of cell death are seen at the lateral edges of the
maxillary and mandibular prominences (arrowheads in G). (I) Normal cell death is seen in the midline of the mandibular prominence and first branchial arch
cleft, the corners of the frontonasal mass and in the nasolacrimal groove (arrowhead). (J–L) Embryos treated with 0.1 g/ml soaked Citral bead. Obvious
deficiency in the lateral nasal prominence by this time point (arrow in J). Box in K and enlargement in L shows similar numbers of apoptotic cells (arrows) to
G, H. Key: b—Citral-soaked bead, ba2—second branchial arch, fnm—frontonasal mass, lnp—lateral nasal prominence, md—mandibular prominence, mxp—
maxillary prominence, np—nasal pit. Scale bar = 500 Am for all panels except D, H, L where it is 100 Am.
Y. Song et al. / Developmental Biology 276 (2004) 313–329320expressed in the developing lateral nasal and maxillary
prominence (Rowe et al., 1991, 1992) and is known to be
directly activated by retinoid acid (Rossant et al., 1991).
We examined expression at 3 h (stage 20.5, before
increases in programmed cell death), 6 h (stage 21,
initiation of apoptosis in the lateral nasal prominence),
and 16 h (stage 22.5, irreversible patterning changes have
taken place, increased apoptosis) following bead implan-
tation. Expression levels were referenced to DMSO or
non-treated, stage-matched controls rather than to the
contralateral side since we wanted to determine if Citral
had bilateral effects on gene expression (Table 2). Msx1
and Bmp4, but not Msx2, were expressed at the start of
our experiment (Figs. 4A, D, G). Expression of Msx1 and
Bmp4 was decreased in the lateral nasal prominence
following Citral treatment (Figs. 4B, C, I–K) and Msx2
failed to upregulate in the globular process (Figs. 4E, F).
There were no discernable effects on maxillary promi-
nence expression of Msx1 and Bmp4 (Figs. 4B, C, J, K).There were also short-term decreases in expression of
Msx1 and Msx2 in the globular process of the contralateral
side that were correlated with effects on the maxillary
process of the premaxilla (Table 2; Figs. 4B, E). In
contrast, Bmp4 transcripts were not reduced in the
globular process on the untreated side at any time point
(Figs. 4I–K; Table 2). Thus, it is conceivable that the
effects on expression of Msx1 and Msx2 in the globular
process are connected to the failure of fusion between the
frontonasal mass and maxillary prominences on the
contralateral side. These expression data refute the idea
that the increase in cell death associated with RALDH
inhibition was caused by an activation of the BMP–Msx-
programmed cell death pathway.
Fgf8 has a dynamic expression pattern restricted to the
ectoderm that changes rapidly between stages 21 and 22.
There is initially expression between the nasal pits (Fig. 4L)
that is rapidly lost within 12 h to be retained only around the
nasal pits at stage 22 (Fig. 4M). Blocking RA synthesis with
Table 2
Temporal changes in expression of cell death and survival genes following unilateral treatment with Citral
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across the frontonasal mass seen at 3 h (Fig. 4N; Table 2). In
addition, the expression failed to upregulate on the lateral
side of the nasal pit as it normally should by 16 h (Figs. 4O,
P, Table 2). The effects of Citral were specific to areas around
the nasal pit since we never observed decreases in Fgf8
expression in the forebrain and the other facial epithelia.
The negligible Fgf8 expression at all time points along
the lateral edge of the nasal pit closely correlated with the
increase in apoptosis seen at 6 and 16 h in the lateral nasal
prominence. However the medial side of the nasal pit
maintained Fgf8 expression at 6 h (n = 8/8) and 16 h n = 3/
4). This maintenance of expression correlates with the lack
of cell death observed in the mesenchyme medial to the
nasal pit (frontonasal mass). To examine more carefully
whether loss of Fgf8 expression precipitated the increased
programmed cell death, we used 10-fold lower soaking
concentrations of Citral. At these concentrations, skeletal
defects still occur but they are not as severe. Unlike our data
with 0.1 g/ml soaked beads, gene expression in the lateral
nasal pit recovered fully by 16 h (Table 2). Apoptosis was
not induced in the lateral nasal prominence mesenchyme
with 0.01 g/ml Citral at 6 or 16 h (n = 6). It is likely that the
early recovery of Fgf8 expression in the lateral nasal
epithelia prevented the increase in apoptosis normally seen
with 0.1 g/ml Citral. These data also clearly show that Fgf8
downregulation was not a consequence of cell death in the
epithelium that expresses this gene.
In contrast to Fgf8, Shh expression at the caudal edge of
the frontonasal mass and the stomodeum did not change
following Citral treatment at any of the time points
examined (22/22, data not shown).
Fgf8 is sufficient to rescue most of the skeletal defects
caused by Citral
The timing of expression changes in Fgf8 suggested that
this gene might be important in mediating the effects of
Citral on facial morphogenesis. We therefore treated
embryos first with Citral (0.1 g/ml) and then 1 h later withFig. 4. Citral-induced cell death is not due to activation of the BMP pathway but is
are non-treated embryos. Panels B, C, E, F, I, J, K, N, O, P are specimens treate
domains and arrows with tails indicate areas with changes in expression througho
implants includes lateral and medial side of the nasal pit and in the maxillary and
(arrows). Bead has fallen out of treated side. (C) Expression remains off on treated
The first visible expression of Msx2 in the frontonasal mass is at medial side of the
on nontreated side (arrows). (F) Expression has recovered on the non-treated side i
(G) Normal expression of Bmp4 at the beginning of the experiment is present on b
expression covering the globular processes of the frontonasal mass and edges of the
on non-treated side around the nasal pit (arrow). (J) Expression is still lacking alon
the bead (arrow). (K) Expression is still lacking along lateral edge of nasal pit (arro
prominence similar to non-treated embryos (arrowhead). (L) Normal expression
(arrowheads), medial side of the nasal pit and in the maxillo-mandibular cleft. Ex
beginning. (M) By stage 22, 12 h later, expression is completely downregulated i
(arrowhead). (N) Expression in frontonasal mass is downregulated except on med
across the frontonasal mass (arrowheads) but remains weak around the nasal pit (ar
prominence removed in this specimen. (P) Expression is absent from the frontonas
of development. Citral expression does not recover on the lateral side of the nas
mxp—maxillary prominence, np—nasal pit, Stg—stage. Scale bars = 500 Am forFGF8b to see whether development could be rescued. The
positive effects of FGF8b were visible externally since there
were far fewer clefts with the combined treatment compared
to the Citral-treated embryos (Table 1D). We also found that
formation of nasal conchae was rescued by FGF8b (64%,
Figs. 5A, B; Table 1C), however, the nasal bone was absent
in the majority of embryos (64%; Fig. 5A). The maxillary
and palatine bone developed in all specimens (Fig. 5B) on
the treated side, however, the protein was not able to rescue
the clefts produced on the opposite side (Fig. 5B; Table 1C).
These data support the premise that Citral is affecting
growth of both sides of the primary palate. FGF8b alone did
not affect skeletal development (Figs. 5C, D). When we
compare the quality of the morphology in the RA and
FGF8b rescued specimens, the RA is more effective (Tables
1B, C), however, the data suggest that by activating the FGF
pathway, some aspects of retinoid signaling are restored. It
was possible that the mechanism for FGF8 rescue may have
been a reduction of programmed cell death in the lateral
nasal prominence. Indeed, the presence of the FGF8-soaked
bead prevented an increase in apoptosis at 6 h (n = 4/5 had
5–10 apoptotic cells, 1/5 had 0 apoptotic cells, Fig. 5E) and
very little apoptosis was observed at 16 h (n = 4/5 had 1–5
apoptotic cells, Fig. 5F). These data fit well with the
observations that the nasal bone is not rescued with FGF8
beads and imply that there is a selective loss of cells that
give rise to intramembranous bone.
FGF8 prevents a Citral-induced decrease in Rarb
expression
To see whether retinoid receptor signaling was affected
by decreased RA synthesis, we investigated expression of
Rarh a receptor known to be expressed in the lateral nasal
prominence and maxillary prominence (Rowe et al., 1991,
1992). In addition, Rarh has a well-defined retinoic acid
receptor response element that confers the gene with
retinoic acid responsiveness (Rossant et al., 1991). Antag-
onism of RALDH with Citral downregulated Rarh
expression in the lateral nasal prominence at 3, 6, and 16correlated with the loss of cell survival factor Fgf8. Panels A, D, G, H, L, M
d with 0.1 g/ml Citral at stage 20. Arrowheads indicate normal expression
ut. (A) Normal expression of Msx1 at stage 21 equivalent to 6 h post bead
mandibular prominences. (B) Citral has eliminated expression on both sides
side (arrow), however, contralateral side has normal signal (arrowhead). (D)
nasal pit (arrowheads). (E) Msx2 failed to upregulate on the treated side or
n the globular process (arrowhead) but is absent on the treated side (arrow).
oth sides of the nasal pit at stage 20 (arrowheads). (H) At stage 22 there is
nasal slit (arrowhead). (I) No expression on treated side and low expression
g lateral edge of nasal pit but there is expression in the globular process near
w) but expression around both globular processes and the anterior maxillary
of Fgf8 at stage 20 includes a band of epithelial signal between nasal pits
pression on the lateral side of the nasal pit is either not yet present or just
n the frontonasal mass epithelium but remains intense around the nasal pits
ial side of right nasal pit (arrows). (O) Expression has partially recovered
row). Bead has fallen out during in situ hybridization (asterisk). Mandibular
al mass and restricted to the nasal pit (arrowhead) as is normal for this stage
al pit (arrow). Key: fnm—frontonasal mass, md—mandibular prominence,
all panels.
Fig. 5. Rescue of Citral skeletal defects with exogenous FGF8. (A, B) Embryo treated with Citral (0.1 g/ml) and FGF8b (1 mg/ml) has good rescue of the nasal
conchae and maxillary process of premaxilla, however the nasal bone is absent on the right. The left side is affected by Citral but is not rescued by FGF8b. The
left palatine bone and maxillary process of the premaxillary bone are much shorter on the left side than on the right. In addition this embryo had a unilateral
cleft on the non-treated side due to shortened maxillary process of premaxilla (asterisk, B). (C, D) Normal skull development with FGF8b-treated embryo
(1 mg/ml). (E, F) Reduction of programmed cell death in the lateral nasal prominence by FGF8b. Apoptotic cells are indicated with arrows in E and in F
inset. Purple bead is heparin acrylic bead soaked in FGF8b. Black bead is SM2 bead soaked in Citral. Key: h—hours, L—left side, j—jugal, mpp—
maxillary process of premaxillary bone; mxb—maxillary bone, n—nasal bone, nc—nasal conchae, p—palatine bone, pp—palatine process of maxillary
bone, qj—quadratojugal, (R)—right side. Scale bar = 5 mm.
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maxillary prominence (Table 3, Figs. 6G, I, K). The
expression of Rarh was generally unaffected on the
contralateral side (Figs. 6H, J, L). Control DMSO-soaked
beads did not affect expression (Figs. 6A–F; Table 3).
FGF8 prevented downregulation of Rarh in the lateral
nasal and maxillary prominences in the majority of speci-
mens at short time intervals (Figs. 6M, O, Q; Table 3) and
this is most obvious at 16 h at which time there is normally
a significant tissue deficit in the lateral nasal prominence
(Table 3, Figs. 6Q, R). We found that FGF8-soaked beads
implanted into the nasal pit did not increase expression ofRarh but occasionally decreased expression (Table 3).
These results in combination with the rescued morphology
suggest that FGF8 is restoring retinoid activity at least as
evidenced by expression of one of the three major types of
RAR receptor, Rarh.Discussion
In this study, we have shown that the nasal pit is an
important source of retinoids in the embryonic face by
locally blocking activity of RALDH with Citral. A
Table 3
Retinoic acid receptor h expression in treated versus FGF8 rescued
embryos
* Area 1—lateral to the nasal pit, Area 5—anterior maxillary prominence.
Key: d—decrease, e—expression present, f—no expression.
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of Citral as evidenced by the ability of exogenous RA to
rescue defects and by the downregulation of Rarh. The
retinoids synthesized in the nasal pit are required for lateral
nasal prominence development and subsequent morpho-
genesis. Our data also suggest that the level of retinoids
may help to promote cell survival and the gene expression
in the nasal pit and adjacent frontonasal mass indicated
that Fgf8 was a potentially important molecule in
controlling cell survival. We demonstrated that by replac-
ing the deficient FGF8 with exogenous protein we could
rescue morphogenesis and programmed cell death. We also
demonstrated the Citral decreases RA signaling by down-
regulating at least one of the receptors, Rarh, and that
FGF8 can rescue Rarh expression.
Functions of retinoid signaling emanating from the nasal pit
Decreased retinoid synthesis impacts most directly on
lateral nasal development. Indeed our results concur with
those of the RALDH3 nullizygous mice (Dupe et al.,
2003). The mouse phenotype includes choanal atresia or
failure of the choana to open between the nasal and oral
cavities and loss of the nasal conchae, persistent
nasolacrimal groove and deficiencies in the maxillary
sinuses. Thus, although other RALDHs may be present in
the face, the type of defect produced by Citral is most
likely attributed to depletion of the retinoic acid that is
normally synthesized by RALDH3.The Citral-treated embryos have large clefts extending
up the medial corner of the eye that are consistent with a
failure of the nasolacrimal groove to be eliminated. These
types of clefts are more analogous to the oblique clefts
described by P. Tessier (Tessier, 1976). There is also a
specific requirement for retinoids in forming the lateral
aspects of the premaxillary bone, which are derived from
the globular process of the frontonasal mass. Inhibition of
retinaldehyde dehydrogenase induces clefts on the treated
side but often also on the opposite side. The clefts on the
untreated side are more similar to human non-syndromic
cleft lip with or without cleft palate since there is a gap
between the premaxillary and maxillary bone.
There are two explanations for bilateral clefts in our
study. The first may be that due to a smaller lateral nasal
prominence, the frontonasal mass is pulled laterally and
out of position for normal fusion. However, there may
also be direct, bilateral effects of Citral on the globular
process and on the maxillary prominence areas we have
shown previously to be critical for fusion (Ashique et al.,
2002). The bilateral skeletal changes and gene expression
changes for Msx1 and Msx2 are consistent with Citral
affecting both sides of the beak. Moreover, the ability of
FGF8 to only rescue clefts on the treated side shows that
the effects of the protein are very local in nature, whereas
Citral is capable of diffusing further from the bead. The
relationship of endogenous retinoids to the two Msx
genes suggests they serve other functions than to induce
programmed cell death. We would argue that they are
essential for outgrowth and patterning since defects in
lateral nasal prominence and globular process are
associated with loss of transcripts. Data from our
previous study illustrate that Bmps, Msx1, and Msx2
are critical for outgrowth and fusion of the frontonasal
and maxillary prominences (Ashique et al., 2002).
Furthermore, human genetic studies point to MSX1
sequence variations as being causative of syndromic cleft
lip (van den Boogaard et al., 2000) or non-syndromic
cleft lip with or without cleft palate (Jezewski et al.,
2003; Marazita et al., 2002). Since one of the most
common mechanisms for clefting is the failure of
approximation of facial processes, it is likely that Msx1
is required for these early stages of face formation.
Retinoids induce and maintain FGFs and thereby promote
cell survival
Our data demonstrate that one of the main functions
of endogenous retinoids is to promote cell survival by
regulating the level of FGFs. Too little retinoids blocks
induction of Fgf8 expression and leads to programmed
cell death best exemplified by the effects of Citral on the
lateral nasal prominence. Such a temporal relationship has
also been shown between the developing prosencephalon
and frontonasal epithelium (Schneider et al., 2001).
However, we have shown that if Fgf8 is previously
Fig. 6. Rarh expression is decreased with Citral and rescued by FGF8. Whole-mount in situ hybridizations with Rarh probe. Each pair of photographs shows
the right and left side of the same embryo. (A–F) Normal expression in DMSO-treated embryos is present on both sides of lateral nasal prominence and anterior
maxillary prominence (arrowheads). White bead is visible inside nasal pit (A, C, E) (G–L) Embryos treated with Citral show downregulation of RARh in the
treated side of lateral nasal prominence and maxillary prominence at 3 and 6 h on the treated (arrows G, I) and also on the contralateral side (arrow, J).
Expression is only decreased in the lateral nasal prominence at 16 h (K, arrow). (M) Citral (lower bead) and FGF8b (upper bead) treated embryos have a rescue
of RARh expression at treated side of lateral nasal prominence but not the maxillary prominence (arrow) compared to the controls and contralateral side (N).
(O) Maintenance of expression in the lateral nasal prominence with FGF8b bead, similar to the contralateral side (P). (Q) Strong expression in the lateral nasal
and maxillary prominences on the treated side (arrowheads) similar to the contralateral side (R). Key: lnp—lateral nasal prominence, md—mandibular
prominence, mxp—maxillary prominence, Scale bar = 500 Am for all panels. Bar in A applies to B, G, H, M, N. Bar in C applies to remainder of the figure.
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our experiment, there was strong expression of Fgf8
along the medial edge of the nasal pit and across the
frontonasal mass at stage 20 and no apoptosis was
induced in these regions. Therefore, we conclude that
reducing retinoid concentrations in a situation where there
is already FGF present does not have serious effects on
development (Fig. 7).
Our data also point toward a secondary role for
retinoids after the normal induction of Fgf8 expression.
Lowering retinoic acid concentrations resulted in de-
creased Fgf8 expression along the medial edge of the
nasal slit and across the center of the frontonasal mass.
The rapid response of the frontonasal mass epithelium to
Citral (3 h) raises the possibility that during normal
development, the levels of retinoids fluctuate in different
regions of the embryo. During development of the face,
the sharp downregulation of FGF in the center of the
frontonasal mass in a relatively short time frame could be
caused by a local decrease in retinoids. However, retinoid
levels probably remain relatively high in close proximity
to the nasal pit (the site of synthesis), therefore, Fgf8
expression is retained in this region. Such relatively rapid
expression changes in the frontonasal mass epithelium
may be facilitated by the presence of a canonical RARE
and a split RARE in the Fgf8 promoter, both of which
bind RARa in liganded and unliganded states, respec-
tively (Brondani et al., 2002). It is generally thought that
in the unliganded state RARa represses transcription,whereas RARh and g do not have this effect (Hauks-
dottir et al., 2003; Privalsky, 2004; Weston et al., 2003).
Rara is present ubiquitously in facial mesenchyme (Mollard
et al., 2000), therefore, the depletion of retinoids in our
experiment may have resulted in unliganded RARa
repressing Fgf8 expression. The control of the FGF8 gene
is therefore complex and may explain why we get effects
when RA is present (expression of Fgf8 around the nasal
pit) and when RA levels are decreased in the center of the
frontonasal mass.
The downregulation of Fgf8 expression appears to be
critical for normal patterning of the frontonasal mass
since a similar temporal pattern is evolutionarily con-
served. An almost identical rapid loss of expression
between the medial nasal prominences is also observed in
mice between E9.5 and E10.0 (Bachler and Neubuser,
2001; Crossley and Martin, 1995). The significance of
this dynamic midfacial Fgf8 expression can be appreci-
ated by the severe truncation of the frontonasal mass in a
mutant chicken strain with sustained Fgf8 in the
frontonasal mass (MacDonald et al., 2004). We showed
that Cpp mutant phenotype is very similar to that
produced by exogenous RA supporting the idea that
retinoids may not decrease as they should in the mutant
frontonasal mass. Similarly, overexpression of FGF8 in
facial epithelia with a retrovirus also truncates outgrowth
(Abzhanov and Tabin, 2004). Thus it is possible that a
balance of retinoids and Fgf8 is required to initiate
outgrowth in the midfacial region.
Fig. 7. Model for how endogenous RA and FGF8 pathways act on each other during frontonasal development. (A) Stage 20 embryo, frontal view with
enlargement of nasal pit showing high levels of retinoic acid in the nasal pit and Fgf8 expression as well as increased RA on the medial side of nasal pit. The
RA produced binds to nuclear dimers of RAR and RXR to activate downstream genes such as Rarh and Fgf8 thereby promoting cell survival. Other genes
such as Bmp4, Msx1, and Msx2 also depend on endogenous RAs to regulate expression, however, no direct response has been demonstrated yet. In addition,
FGFs may independently activate Rarb expression via unknown intermediates (Bhasin et al., 2003). (B) Stage 22 embryo with enlargement of nasal slit area.
There is a decrease in RA levels as well as an absence of FGF8 medial to the nasal pit. This may lead to unliganded RARa which acts as a repressor on Fgf8
expression (Brondani et al., 2002). This downregulation of Fgf8 is required for normal outgrowth. Key: FNM—frontonasal mass, LNP—lateral nasal
prominence, RA—retinoic acid, RAR—retinoic acid receptor, RARE—retinoic acid receptor response element.
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Our Rarh gene expression data and the presence of
RAREs in the promoter of Fgf8 (Brondani et al., 2002)
suggested the possibility that FGFs were downstream of
endogenous retinoid signaling. The rescue of the Citral
phenotype by addition of the exogenous FGF8 protein is
another piece of evidence that retinoids are upstream of
FGFs. However, it is equally possible that FGFs can directly
rescue the deficient retinoid-signaling pathway. It has been
shown that FGF8 induces RALDH2 protein and Rarb
transcripts in organ cultures of mouse medial nasal and
lateral nasal prominences, however, Raldh3 expression is
unchanged (Bhasin et al., 2003). Our rescue data from a
system where three-dimensional morphogenesis is possible
support the idea that FGF8 is able to rescue some aspects of
retinoid signaling, as judged by the maintenance of Rarh
expression in the lateral nasal prominence and the preven-
tion of apoptosis.
A progressive model for patterning the frontonasal region
with retinoids and FGFs
During development, we see the role for retinoids as
being necessary to control development of the frontonasal
region beginning with the induction of the nasal placodes byretinoid signals emanating from the forebrain (Schneider et
al., 2001). What is the genetic evidence supporting a role for
retinoid synthesis in establishing first the nasal pits and then
the frontonasal region? There is no information on the
expression of Fgf8 in the Raldh2ko mice however develop-
ment of the forebrain appears to be impaired and nasal
placodes are hardly visible (Niederreither et al., 1999). The
knockout of Raldh3 appears to have normal Fgf8 expression
at earlier times judging by the relatively normal brain, nasal
pit, and frontonasal development (Dupe et al., 2003). These
data are consistent with a major role for RALDH2 in
establishing the early frontonasal patterning and nasal pits
while RALDH3 is involved in later patterning events.
The frontonasal mass mesenchyme increases in thickness
gradually separating the brain from the overlying epithe-
lium. During this period, the forebrain may also cease to be
a generator of retinoic acid as evidenced by lack of
expression of Raldh2 or Raldh3 at stage 20 (Blentic et al.,
2003). Instead, the nasal placodes take over as the main
tissues that synthesize retinoids. Our data showed that
retinoids from the placodes play several roles: (1) the
control of Fgf8 expression and via expression of this gene
the control of cell survival, (2) the control of BMP pathway
genes, Bmp4, Msx1, and Msx2, and (3) morphogenesis of
the lateral nasal prominence and globular process. We also
show that in addition to retinoids acting on the FGF
Y. Song et al. / Developmental Biology 276 (2004) 313–329328pathway the reverse is also possible. FGFs acting via
tyrosine kinase receptors regulate Rarh expression and this
is linked to a rescue of morphogenesis.
If retinoids and Fgfs act in an epistatic manner similar
phenotypes should be produced by loss of function of Fgf8
and RALDH. Indeed, the branchial arch phenotypes of RA-
rescued Raldh2ko embryos or RAR antagonist-treated
embryos resemble those of FGF8 hypomorphs (Abu-Issa et
al., 2002; Niederreither et al., 2001; Wendling et al., 2000).
There are also some similarities in the heart phenotypes of
mice with decreased Fgf8 and decreased retinoid signaling.
Together, these data support the concept that FGF8 and
retinoic acid regulate common developmental pathways.
That endogenous retinoids and Fgfs have overlapping
functions is also born out elsewhere in the embryo. For
example, limb bud initiation is dependent on RALDH2
(Niederreither et al., 1999, 2002) and FGF activity (Min et al.,
1998; Sekine et al., 1999; Sun et al., 2002). It may be an
advantage to have two different molecular pathways control
the same developmental process. Therefore, in cases where
one pathway is not able to function normally, the other may
permit development to proceed. We have examined in detail
the control of local cell survival around the nasal placode and
determined that functions of endogenous retinoids and FGFs
overlap help to sculpt the face by regulating cell survival.Acknowledgments
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